Showing results (151-160 of 179) with videos related to
Sort By:
Pageof 18
Infectious Diseases and Therapy|July 21, 2022
Correlation Between Cefoperazone/Sulbactam MIC Values and Clinical Outcomes of Escherichia coli BacteremiaShang-Yi Lin, Po-Liang Lu, Ting-Shu Wu, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 22, 2010
A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumanniiWang-Huei Sheng, Chun-Hsing Liao, Tsai-Ling Lauderdale, et al.Jac-Antimicrobial Resistance|May 13, 2026
Clinical implications of cefoperazone-sulbactam MIC values in Pseudomonas aeruginosa bloodstream infections: a multicentre studyShian-Sen Shie, Ting-Shu Wu, Feng-Yee Chang, et al.International Journal of Antimicrobial Agents|March 20, 2013
Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009Shio-Shin Jean, Po-Ren Hsueh, Wen-Sen Lee, et al.Plos One|September 13, 2011
Seroprevalence and severity of 2009 pandemic influenza A H1N1 in TaiwanChih-Jung Chen, Ping-Ing Lee, Shih-Cheng Chang, et al.Vaccine|July 21, 2009
National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potentialYu-Chia Hsieh, Pen-Yi Lin, Cheng-Hsun Chiu, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 12, 2024
Multicenter study on clinical outcomes and poor prognostic factors in patients with Klebsiella pneumoniae bacteremia receiving cefoperazone/sulbactam treatmentTsung-Ta Chiang, Ming-Hsien Chiang, Hung-Jen Tang, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|February 10, 2015
Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)Shio-Shin Jean, Wen-Sen Lee, Kwok-Woon Yu, et al.Plos One|August 9, 2016
The Critical Role of Early Dengue Surveillance and Limitations of Clinical Reporting - Implications for Non-Endemic CountriesJui-Hung Kao, Chaur-Dong Chen, Zheng-Rong Tiger Li, et al.Plos One|July 25, 2018
Correction: The Critical Role of Early Dengue Surveillance and Limitations of Clinical Reporting - Implications for Non-Endemic CountriesJui-Hung Kao, Chaur-Dong Chen, Zheng-Rong Tiger Li, et al.Pageof 18